{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:40:40Z","timestamp":1790185240323,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T00:00:00Z","timestamp":1307923200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020571","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:04:50Z","timestamp":1308341090000},"page":"e20571","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":107,"title":["Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation"],"prefix":"10.1371","volume":"6","author":[{"given":"Johan","family":"Fern\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silje","family":"Skrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Nogueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Di\u00e9guez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vidal-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar M.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis.","volume":"156","author":"DB Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.v65n0219","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes.","volume":"65","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"ref3","first-page":"A42","article-title":"Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.","volume":"3","author":"CW Colton","year":"2006","journal-title":"Prev Chronic Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance.","volume":"66","author":"PJ Weiden","year":"2004","journal-title":"Schizophr Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/oby.2008.277","article-title":"Adiposity and eating behaviors in patients under second generation antipsychotics.","volume":"16","author":"M Blouin","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00213-005-2224-4","article-title":"A parametric analysis of olanzapine-induced weight gain in female rats.","volume":"181","author":"GD Cooper","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0091-3057(03)00042-X","article-title":"Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human.","volume":"75","author":"B Pouzet","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-002-1368-8","article-title":"Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.","volume":"167","author":"AW Hartfield","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/sj.npp.1300949","article-title":"Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats.","volume":"31","author":"AW Hartfield","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.","volume":"13","author":"HA Nasrallah","year":"2008","journal-title":"Mol Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.","volume":"125","author":"GP Reynolds","year":"2010","journal-title":"Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tibs.2003.11.005","article-title":"The AMP-activated protein kinase cascade--a unifying system for energy control.","volume":"29","author":"D Carling","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1073\/pnas.1834402100","article-title":"Hypothalamic malonyl-CoA as a mediator of feeding behavior.","volume":"100","author":"Z Hu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.","volume":"1","author":"BB Kahn","year":"2005","journal-title":"Cell Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.molmed.2008.09.007","article-title":"AMPK: a metabolic gauge regulating whole-body energy homeostasis.","volume":"14","author":"R Lage","year":"2008","journal-title":"Trends Mol Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/bies.20539","article-title":"Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake.","volume":"29","author":"M L\u00f3pez","year":"2007","journal-title":"Bioessays"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature05026","article-title":"Central nervous system control of food intake and body weight.","volume":"443","author":"GJ Morton","year":"2006","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0269881106061199","article-title":"Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus.","volume":"20","author":"SL Kirk","year":"2006","journal-title":"J Psychopharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2006.01.002","article-title":"Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats.","volume":"40","author":"XF Huang","year":"2006","journal-title":"Neuropeptides"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00213-008-1415-1","article-title":"Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.","volume":"203","author":"N Davoodi","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbr.2009.09.032","article-title":"Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance.","volume":"207","author":"B Guesdon","year":"2010","journal-title":"Behav Brain Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase.","volume":"104","author":"SF Kim","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cmet.2008.03.006","article-title":"Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.","volume":"7","author":"M L\u00f3pez","year":"2008","journal-title":"Cell Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/db05-1356","article-title":"Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA.","volume":"55","author":"M L\u00f3pez","year":"2006","journal-title":"Diabetes"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nm.2207","article-title":"Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.","volume":"16","author":"M L\u00f3pez","year":"2010","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature02440","article-title":"AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.","volume":"428","author":"Y Minokoshi","year":"2004","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/ijo.2008.123","article-title":"Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.","volume":"32","author":"MD Lane","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2010.07.002","article-title":"Preclinical models of antipsychotic drug-induced metabolic side effects.","volume":"31","author":"HN Boyda","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.","volume":"14","author":"VL Albaugh","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pnpbp.2007.09.012","article-title":"Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.","volume":"32","author":"GD Cooper","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/026988110201600402","article-title":"Characterization of olanzapine-induced weight gain in rats.","volume":"16","author":"AJ Goudie","year":"2002","journal-title":"J Psychopharmacol"},{"key":"ref32","first-page":"121","article-title":"An animal model of antipsychotic-induced weight gain.","volume":"152","author":"AA Arjona","year":"2004","journal-title":"Behav Brain Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/JCP.0b013e3181bfe13e","article-title":"30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice.","volume":"29","author":"R Coccurello","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/jpet.108.137240","article-title":"Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice.","volume":"326","author":"R Coccurello","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00213-006-0368-5","article-title":"Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.","volume":"186","author":"R Coccurello","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"ref36","first-page":"e55","article-title":"Chronic administration of olanzapine affects Behavioral Satiety Sequence and feeding behavior in female mice.","volume":"13","author":"R Coccurello","year":"2008","journal-title":"Eat Weight Disord"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881104042613","article-title":"Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.","volume":"18","author":"MJ Fell","year":"2004","journal-title":"J Psychopharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.appet.2006.01.008","article-title":"Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.","volume":"46","author":"J Minet-Ringuet","year":"2006","journal-title":"Appetite"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-006-0433-0","article-title":"A model for antipsychotic-induced obesity in the male rat.","volume":"187","author":"J Minet-Ringuet","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.2337\/db10-0449","article-title":"Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance.","volume":"59","author":"PJ Martins","year":"2010","journal-title":"Diabetes"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-008-1370-x","article-title":"Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver.","volume":"203","author":"J Ferno","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.","volume":"100","author":"H Jin","year":"2008","journal-title":"Schizophr Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00125-004-1596-z","article-title":"A possible role of neuropeptide Y, agouti-related protein and leptin receptor isoforms in hypothalamic programming by perinatal feeding in the rat.","volume":"48","author":"M L\u00f3pez","year":"2005","journal-title":"Diabetologia"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0029665107005368","article-title":"Peripheral tissue-brain interactions in the regulation of food intake.","volume":"66","author":"M L\u00f3pez","year":"2007","journal-title":"Proc Nutr Soc"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/en.2007-1708","article-title":"Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion.","volume":"149","author":"MJ Vazquez","year":"2008","journal-title":"Endocrinology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2826.2010.01994.x","article-title":"Influence of ghrelin and growth hormone deficiency on AMP-activated protein kinase and hypothalamic lipid metabolism.","volume":"22","author":"S Sangiao-Alvarellos","year":"2010","journal-title":"Journal of neuroendocrinology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature07181","article-title":"UCP2 mediates ghrelin&apos;s action on NPY\/AgRP neurons by lowering free radicals.","volume":"454","author":"ZB Andrews","year":"2008","journal-title":"Nature"},{"key":"ref48","first-page":"R43","article-title":"Ghrelin and lipid metabolism: key partners in energy balance.","volume":"46","author":"L Varela","year":"2011","journal-title":"Journal of molecular endocrinology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2008.08.003","article-title":"The AMPK-malonyl-CoA-CPT1 axis in the control of hypothalamic neuronal function.","volume":"8","author":"M L\u00f3pez","year":"2008","journal-title":"Cell Metab"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1096\/fj.09-150672","article-title":"Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender.","volume":"24","author":"R Lage","year":"2010","journal-title":"The FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.ijo.0802928","article-title":"Antipsychotic drug-induced weight gain: development of an animal model.","volume":"29","author":"MB Cope","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1172\/JCI31183","article-title":"Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis.","volume":"117","author":"MV Chakravarthy","year":"2007","journal-title":"The Journal of clinical investigation"},{"key":"ref53","article-title":"The rat brain in stereotaxic coordinates.","author":"G Paxinos","year":"1986"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T12:36:55Z","timestamp":1686141415000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020571"}},"subtitle":[],"editor":[{"given":"Silvana","family":"Gaetani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,13]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020571","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,13]]}}}